Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 25 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

GI disorders influenced by anxiety in inactive IBD

Many patients with inactive IBD have symptoms of functional GI disorders, with anxiety independently predicting functional GI disorders, and both impair health related quality of life, reports January's Inflammatory Bowel Diseases.

News image

fiogf49gjkf04

Symptoms of functional gastrointestinal (GI) disorders associated with mood disorders occur in some patients with quiescent inflammatory bowel disease (IBD).

The mood disorders include depression and anxiety, and could be caused by changes in gut motility, visceral hypersensitivity, or psychological dysfunction.

Dr Forough Farrokhyar and colleagues assessed the prevalence of GI symptoms and mood disorders in patients with quiescent IBD.

The research team evaluated the impact on health related quality of life and use of health resources.

The team surveyed 361 patients, of which 149 had IBD during the previous 12 months.

Mood disorders occurred in 27% with ulcerative colitis and 31% with Crohn's disease
Inflammatory Bowel Diseases

Of the included patients, 44 had ulcerative colitis, and 105 had Crohn's disease.

The patients completed a survey of Rome II criteria for functional gastrointestinal disorders, as well as the Hospital Anxiety and Depression Survey.

Health related quality of life indices, and health resource utilization were assessed.

The team used logistic and linear regression analyses to test for predictors of functional gastrointestinal disorders and health related quality of life.

The research team found symptoms of at least 1 functional gastrointestinal disorder in 82%.

Functional anorectal disorders were the most prevalent followed by functional bowel disorders.

The team noted that both were of greater prevalence than in the general population.

Irritable bowel syndrome symptoms were more common in inactive Crohn's disease than in ulcerative colitis.

The researchers observed that functional constipation was more common in inactive ulcerative colitis than in Crohn's disease.

Mood disorders occurred in 27% of ulcerative colitis and 31% of Crohn's disease patients.

The team identified that age 40 years or older, and anxiety independently predicted functional gastrointestinal disorders.

Both functional gastrointestinal disorders symptoms and mood disorders were associated with impaired health related quality of life.

In addition, the team found that both were associated with an increased use of health services.

Dr Farrokhyar's team commented, “Many patients with inactive inflammatory bowel disease have symptoms compatible with functional gastrointestinal disorders.”

“Both functional gastrointestinal disorders-like symptoms and mood disorders are associated with impaired health related quality of life and increased health resource utilization.”

“Recognition and treatment of functional gastrointestinal disorders and mood disorders could potentially improve daily functioning of inflammatory bowel disease patients.”

Inflamm Bowel Dis 2006: 12(1): 38-46
05 January 2006

Go to top of page Email this page Email this page to a colleague

 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Autoimmune pancreatitis in children
 01 November 2017 
Heartburn relief in adolescents with GERD
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us